021-51111890
购物车（）
sales@molnova.cn
Avatrombopag
CAS No. 570406-98-3
Avatrombopag ( AKR-501; E5501; YM477 )
产品货号. M20798 CAS No. 570406-98-3
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥680 | 有现货 |
|
| 5MG | ￥996 | 有现货 |
|
| 10MG | ￥1596 | 有现货 |
|
| 25MG | ￥2892 | 有现货 |
|
| 50MG | ￥4836 | 有现货 |
|
| 100MG | ￥6901 | 有现货 |
|
| 500MG | ￥14013 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Avatrombopag
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
-
产品描述Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
-
同义词AKR-501; E5501; YM477
-
通路Others
-
靶点Other Targets
-
受体TPO
-
研究领域Cardiovascular Disease
-
适应症Idiopathic thrombocytopenic purpura
化学信息
-
CAS Number570406-98-3
-
分子量649.65
-
分子式C29H34Cl2N6O3S2
-
纯度>98% (HPLC)
-
溶解度DMSO:32 mg/mL (49.26 mM)
-
SMILESO=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Xu H Cai R.Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease.Expert Rev Clin Pharmacol. 2019 Sep;12(9):859-865?
产品手册
关联产品
-
(3S,5S,E)-1,7-Diphen...
(3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol has anti-oomycete potential.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Astin B
Astin B has antitumor activity.
